Budget impact analysis of the introduction of ranibizumab's biosimilar to the Jordanian joint procurement system.
Saved in:
| Title: | Budget impact analysis of the introduction of ranibizumab's biosimilar to the Jordanian joint procurement system. |
|---|---|
| Authors: | Hamida JA; Department of Biopharmaceutics and Clinical Pharmacy, School of Pharmacy, The University of Jordan, Amman, Jordan., Alkhatib NS; Al-Zaytoonah University of Jordan Faculty of Pharmacy, Amman, Jordan.; Path Economics, LLC, Amman, Jordan., Hammour KA; Department of Biopharmaceutics and Clinical Pharmacy, School of Pharmacy, The University of Jordan, Amman, Jordan., Halloush S; Clinical Pharmacy and Therapeutics Department, Faculty of Pharmacy, Applied Science Private University, Amman, Jordan., Kurdi A; University of Strathclyde Institute of Pharmacy and Biomedical Sciences, Glasgow, United Kingdom., Balkhi B; King Saud University College of Pharmacy, Riyadh, Saudi Arabia., Alfayez OM; Department of Pharmacy Practice, College of Pharmacy, Qassim University, Qassim, Saudi Arabia., Mousa R; Department of Biopharmaceutics and Clinical Pharmacy, School of Pharmacy, The University of Jordan, Amman, Jordan. |
| Source: | Frontiers in public health [Front Public Health] 2026 May 07; Vol. 14, pp. 1800784. Date of Electronic Publication: 2026 May 07 (Print Publication: 2026). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Editorial Office Country of Publication: Switzerland NLM ID: 101616579 Publication Model: eCollection Cited Medium: Internet ISSN: 2296-2565 (Electronic) Linking ISSN: 22962565 NLM ISO Abbreviation: Front Public Health Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
